INSP Aug 2023 300.000 call
| Previous close | 31.90 |
| Open | 31.90 |
| Bid | 21.70 |
| Ask | 22.60 |
| Strike | 300.00 |
| Expiry date | 2023-08-18 |
| Day's range | 31.90 - 31.90 |
| Contract range | N/A |
| Volume | |
| Open interest | 11 |
Zacks3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio
Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.
GlobeNewswireInspire Medical Systems, Inc. to Participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series
MINNEAPOLIS, May 16, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series on Monday, May 22, 2023. Inspire is scheduled to present at 2:00 p.m. Eastern Time. The presentation will be accessib
Simply Wall St.Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 32% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Inspire Medical Systems fair value estimate is US$203 Inspire...
ZacksInspire Medical (INSP) Q1 Earnings & Revenues Top Estimates
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the first quarter.
- GlobeNewswire
UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023. Inspire is now scheduled to present at 1:00 p.m. Eastern Time. The presentation will be accessible via
- GlobeNewswire
Inspire Medical Systems, Inc. to Present at the RBC Capital Markets 2023 Global Healthcare Conference
MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the RBC Capital Markets 2023 Global Healthcare Conference on Tuesday, May 16, 2023. Inspire is scheduled to present at 1:35 p.m. Eastern Time. The presentation will be accessible
ZacksInspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Inspire (INSP) delivered earnings and revenue surprises of 24.29% and 6.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Inspire Medical Systems, Inc. Announces First Quarter 2023 Financial Results and Updates 2023 Outlook
Inspire Reports Year-over-Year Revenue Growth of 84% in the First QuarterMINNEAPOLIS, May 02, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today reported financial results for the quarter ended March 31, 2023. Recent Business Highlights Generated revenue of $127.9 million in the first quarter o
- GlobeNewswire
Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
MINNEAPOLIS, April 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023. Inspire is scheduled to present at 11:40 a.m. Eastern Time. The presentation will be accessible via
- Simply Wall St.
Inspire Medical Systems, Inc.'s (NYSE:INSP) P/S Is On The Mark
Inspire Medical Systems, Inc.'s ( NYSE:INSP ) price-to-sales (or "P/S") ratio of 19x might make it look like a strong...
ZacksWhat Makes Inspire (INSP) a New Buy Stock
Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksZacks Industry Outlook Highlights Inspire Medical Systems, Olink Holding and Health Catalyst
Inspire Medical Systems, Olink Holding and Health Catalyst have been highlighted in this Industry Outlook article.
Zacks3 Medical Info Systems Stocks Countering Industry-wide Headwinds
Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Olink Holding (OLK) and Health Catalyst (HCAT) are expected to gain even as COVID-19 severity fades.
- GlobeNewswire
Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023
MINNEAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2023 after the close of trading on Tuesday, May 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspir
- Simply Wall St.
Inspire Medical Systems, Inc. (NYSE:INSP): When Will It Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Inspire Medical Systems...
- GlobeNewswire
Inspire Medical Systems, Inc. Announces FDA Approval for Pediatric Patients with Down Syndrome
MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received approval from the Food and Drug Administration (FDA) to offer Inspire therapy to pediatric patients with Down syndrome. “Since our first FDA approval in 2014, the research team at Mass Eye a
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium
MINNEAPOLIS, March 09, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received countrywide reimbursement approval in Belgium, effective immediately, at rates consistent with other countries around the world. “The healthcare team at Antwerp University Hospital (UZA) in
- GlobeNewswire
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
MINNEAPOLIS, March 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023. Inspire is scheduled to present at 9:00 a.m. Eastern Time. The presentati
- Simply Wall St.
Inspire Medical Systems Full Year 2022 Earnings: EPS Beats Expectations
Inspire Medical Systems ( NYSE:INSP ) Full Year 2022 Results Key Financial Results Revenue: US$407.9m (up 75% from FY...
- Zacks
Inspire Medical (INSP) Q4 Earnings, Revenues Top Estimates
Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the fourth quarter.
ZacksInspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates
Inspire (INSP) delivered earnings and revenue surprises of 118.52% and 0.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
Inspire Reports First Profitable Quarter and Year-over-Year Revenue Growth of 76% in the Fourth QuarterMINNEAPOLIS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and full year ended December 31, 2022, and provided full year 2023 guidance. Recen
ZacksInspire Medical Systems (INSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motley FoolThe Ultimate Growth Stocks to Buy With $300 Right Now
Long-term investors looking to overcome the effects of inflation can find some satisfaction from quality growth stocks, especially from companies generating triple-digit growth in revenue and share-price appreciation. Shares of Inspire Medical Systems (NYSE: INSP), Axsome Therapeutics (NASDAQ: AXSM), and Abermarle (NYSE: ALB) can all be purchased for under $300. All three companies have had triple-digit percentage revenue and share-price growth over the past five years.
- GlobeNewswire
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023
MINNEAPOLIS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2022 after the close of trading on Tuesday, February 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through t